Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SuMR: Sunitinib before and after nephrectomy in mRCC
NCT01024205Phase 2Completed
- Sponsor
- Barts and The London School of Medicine and Dentistry
- Start
- Aug 2007
- Primary completion
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sunitinib in renal cell carcinoma (RCC), sponsored by Barts and The London School of Medicine and Dentistry. Started Aug 2007; status: completed.
02
Drugs
sunitinib
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT01024205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01024205.